Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of the Tumor Microenvironment in Regulating Pancreatic Cancer Therapy Resistance
Daiyong Deng, Riya Patel, Cheng-Yao Chiang, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 2952-2952
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Metformin Improves Ovarian Cancer Sensitivity to Paclitaxel and Platinum-Based Drugs: A Review of In Vitro Findings
Giovanni Tossetta
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12893-12893
Open Access | Times Cited: 51
The role of macrophages in the tumor microenvironment and tumor metabolism
Pritam Sadhukhan, Tanguy Y. Seiwert
Seminars in Immunopathology (2023) Vol. 45, Iss. 2, pp. 187-201
Closed Access | Times Cited: 26
Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application
Rui Zheng, Xiaobin Liu, Yufu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
microRNAs Associated with Gemcitabine Resistance via EMT, TME, and Drug Metabolism in Pancreatic Cancer
Naotake Funamizu, Masahiko Honjo, Kei Tamura, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1230-1230
Open Access | Times Cited: 11
Pancreatic stellate cell: Update on molecular investigations and clinical translation in pancreatic cancer
Yawei Liu, Ran Xue
International Journal of Cancer (2025)
Closed Access
Knocking down GALNT6 promotes pyroptosis of pancreatic ductal adenocarcinoma cells through NF-κB/NLRP3/GSDMD and GSDME signaling pathway
Mengyang Ding, Jingyu Liu, Honghui Lv, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
Characterization of immune microenvironment in patients with HPV-positive and negative head and neck cancer
Zhongqiu Wang, Qingxin Wang, Yuxuan Tao, et al.
Scientific Data (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 10
Bioengineering Approaches for the Pancreatic Tumor Organoids Research and Application
Taiyu Song, Bin Kong, Rui Liu, et al.
Advanced Healthcare Materials (2023) Vol. 13, Iss. 1
Closed Access | Times Cited: 9
Molecular understanding and clinical aspects of tumor-associated macrophages in the immunotherapy of renal cell carcinoma
Han Liu, Zongwei Lv, Gong Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 3
Locoregional Therapies and Remodeling of Tumor Microenvironment in Pancreatic Cancer
Maria Caterina De Grandis, Velio Ascenti, Carolina Lanza, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12681-12681
Open Access | Times Cited: 8
Green Nanotechnology of Yucca filamentosa- Phytochemicals-Functionalized Gold Nanoparticles—Antitumor Efficacy Against Prostate and Breast Cancers
Velaphi C. Thipe, Ananya Jatar, Alice Raphael Karikachery, et al.
Nanotechnology Science and Applications (2023) Vol. Volume 16, pp. 19-40
Open Access | Times Cited: 7
MSLN induced EMT, cancer stem cell traits and chemotherapy resistance of pancreatic cancer cells
Jili Hu, Wang Jia, Xu Guo, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e29210-e29210
Open Access | Times Cited: 2
New avenues for the treatment of immunotherapy-resistant pancreatic cancer
Luis Guilherme de Oliveira Silva, Fabian Fellipe Bueno Lemos, Marcel Silva Luz, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 4, pp. 1134-1153
Open Access | Times Cited: 2
Breaking Down Barriers in Drug Delivery by Stromal Remodeling Approaches in Pancreatic Cancer
Ying Zhou, Yunxiao Ma, Jingdan Sheng, et al.
Molecular Pharmaceutics (2024)
Closed Access | Times Cited: 2
Advancing Immunotherapy in Pancreatic Cancer
Ahmad Hegazi, Lauren Elizabeth Rager, Dean Watkins, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11560-11560
Open Access | Times Cited: 2
Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic Opportunities
Ana Bogut, Bojan Stojanović, Marina Jovanović, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15500-15500
Open Access | Times Cited: 6
A novel anti-galectin-9 immunotherapy limits the early progression of pancreatic neoplastic lesions in transgenic mice
Alexandre Quilbé, Rami Mustapha, Bélinda Duchêne, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Exosomal miRNAs in the microenvironment of pancreatic cancer
Xinlei Zou, Ziyue Huang, Canghai Guan, et al.
Clinica Chimica Acta (2023) Vol. 544, pp. 117360-117360
Closed Access | Times Cited: 4
LncRNA ZNF649-AS1 promotes trastuzumab resistance and TAM-dependent PD-L1 expression in breast cancer by regulating EXOC7 alternative splicing
Huaying Dong, Jing Han, Xiang Chen, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 761, pp. 110128-110128
Closed Access | Times Cited: 1
Multidimensional screening of pancreatic cancer spheroids reveals vulnerabilities in mitotic and cell-matrix adhesion signaling that associate with metastatic progression and decreased patient survival
Albert-Fred Aquino, Farhana Runa, Jannatul F. Shoma, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 703, pp. 149575-149575
Open Access
Tumor microenvironment components in pancreatic cancer
Zoya Alam, Abhayananda Behera, Elina Rani Maddimadugu, et al.
Elsevier eBooks (2024), pp. 17-24
Closed Access
Reversal of T-cell exhaustion: Mechanisms and synergistic approaches
Yang Hu, Yaqi Zhang, Fenfen Shi, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112571-112571
Closed Access
Oncometabolites in pancreatic cancer: Strategies and its implications
Arunima Maiti, Susmita Mondal, Shouvik Choudhury, et al.
World Journal of Experimental Medicine (2024) Vol. 14, Iss. 4
Closed Access
Radioresistance-related gene signatures identified by transcriptomics characterize the prognosis and immune landscape of pancreatic cancer patients
Dandan Wang, Jun Cao, Yanhui Chen, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
A polyethylene glycol-conjugate of deoxycytidine analog, DFP-14927, produces potential antitumor effects on pancreatic tumor-xenograft murine models via inducing G2/M arrest
Hidenori Ando, Kiyoshi Eshima, Tatsuhiro Ishida
European Journal of Pharmacology (2023) Vol. 950, pp. 175758-175758
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top